Bush says the problem was that patients weren't getting enough of a B vitamin, and that no such safety issues have showed up in the current trial.

FORBES: Magazine Article

Vitamin manufacturers are to invited to submit evidence of the efficacy and safety of their high-dose products.

BBC: Clampdown on 'high-dose' vitamins